Despite treatment, approximately 20% of patients with asthma have uncontrolled, moderate-to-severe disease, with substantially reduced lung function and the risk of further loss of function over time. Full study: nej.md/2LhxmaA
Пікірлер: 6
@armin78553 жыл бұрын
Anyone here from Pharmacology @Deakin ?
@kaijiesoo85883 жыл бұрын
hello! just watching it now and cramming for the test in four days lmaooo
@armin78553 жыл бұрын
@@kaijiesoo8588 Hahaha. Same
@mimi-lo4fb2 жыл бұрын
omg I’m doing last min revision for that unit rn - the exam is tmrw 💀
@roshanur6 жыл бұрын
what about a trial of Dupilumab vs a LAMA/LABA/zafirlukast? how much better is it over these drugs?
@nordicfreya6713 жыл бұрын
Wounder why my bones hurt like crazy with Dupilumab 🥴